Action Levels for Lead in Juice: Guidance for Industry Original paper

Researched by:

  • Dr. Umar Aitsaam ID
    Dr. Umar Aitsaam

    User avatarClinical Pharmacist and Master’s student in Clinical Pharmacy with research interests in pharmacovigilance, behavioral interventions in mental health, and AI applications in clinical decision support. Experience includes digital health research with Bloomsbury Health (London) and pharmacovigilance practice in patient support programs. Published work covers drug awareness among healthcare providers, postpartum depression management, and patient safety reporting.

    Read More

January 21, 2026

Researched by:

  • Dr. Umar Aitsaam ID
    Dr. Umar Aitsaam

    User avatarClinical Pharmacist and Master’s student in Clinical Pharmacy with research interests in pharmacovigilance, behavioral interventions in mental health, and AI applications in clinical decision support. Experience includes digital health research with Bloomsbury Health (London) and pharmacovigilance practice in patient support programs. Published work covers drug awareness among healthcare providers, postpartum depression management, and patient safety reporting.

    Read More

Last Updated: 2026-01-21

Our team of researchers are constantly monitoring and summarizing the latest research,
and we continue to update our pages to ensure you have the most accurate information.

Note on the last update: One new meta analysis added

Dr. Umar Aitsaam

Clinical Pharmacist and Master’s student in Clinical Pharmacy with research interests in pharmacovigilance, behavioral interventions in mental health, and AI applications in clinical decision support. Experience includes digital health research with Bloomsbury Health (London) and pharmacovigilance practice in patient support programs. Published work covers drug awareness among healthcare providers, postpartum depression management, and patient safety reporting.

What was reviewed?

This FDA draft guidance reviewed action levels for lead in juice and the scientific/regulatory rationale for lowering the long-standing recommended level of 50 ppb to new, juice-type–specific action levels. It frames lead as a toxic element with no identified safe exposure level for children, links contamination to agricultural inputs and legacy processing equipment, and positions the guidance within FDA’s “Closer to Zero” iterative risk-reduction approach. The document explains why FDA re-evaluated prior benchmarks using U.S. marketplace data (domestic and imported) and why achievability matters for compliance, enforcement discretion, and public-health impact—especially for products heavily consumed by infants and young children.

Who was reviewed?

Rather than enrolling human subjects, the guidance synthesizes evidence about populations most vulnerable to dietary lead exposure—infants, young children, pregnant women, and fetuses—and uses these groups to justify protective targets. It also implicitly “reviews” the regulated community: juice manufacturers, processors, and importers operating under Juice HACCP and current good manufacturing practices, because the guidance is designed to be achievable when industry takes measures to minimize lead. In practice, the “who” is the supply chain that determines lead levels in finished juice (produce sourcing, processing equipment, blending decisions, and quality systems), plus regulators who may use the action levels when evaluating whether covered juice products could be regarded as adulterated and when considering enforcement actions case-by-case.

Most important findings

For HMTC certification, the guidance’s most operational content is the proposed, product-specific action levels and the rationale tying them to children’s intake reference levels and consumption patterns, especially apple juice.

Critical pointDetails
Proposed action levelsFDA proposes 10 ppb lead for single-strength apple juice and 20 ppb for other single-strength juices, including blends that contain apple juice.
Why apple juice is lowerApple juice is identified as the most commonly consumed juice by young children in the U.S., supporting a more protective threshold.
Estimated exposure reductionFDA estimates 10 ppb apple juice would reduce children’s dietary lead exposure by 46% at the 90th percentile consumption level; 20 ppb other juices would reduce exposure by 19% at the 90th percentile.
Enforcement relevanceThe action levels (though nonbinding) are intended to help define levels at which covered juices may be regarded as adulterated and may inform FDA enforcement decisions alongside other factors.
Contamination sources to controlLead can enter juice via the produce used to make it and via older lead-containing processing equipment (e.g., lead-soldered machinery), reinforcing preventive controls and equipment assessment.
Alignment and differences vs CodexFDA notes Codex maximum levels were updated using international data (e.g., lower MLs for some juice categories), while FDA’s proposed action levels reflect U.S. marketplace data and public-health priorities.

Key implications

Primary regulatory impacts center on using action levels for lead in juice as practical enforcement and adulteration benchmarks that also motivate HACCP-aligned prevention. For certification requirements, HMTC can map pass/fail criteria to 10 ppb (apple) and 20 ppb (other juices) on a ready-to-drink basis, requiring validated lab methods at low ppb ranges and lot-level verification for blends. Industry applications include supplier qualification for high-risk produce inputs and documented equipment risk reviews. Research gaps remain around commodity-specific drivers for “other juices,” variability by geography, and the most effective interventions upstream. Practical recommendations include setting tighter internal targets below FDA action levels, trend-monitoring results, and integrating corrective actions into HACCP plans.

Citation

U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition. Action Levels for Lead in Juice: Guidance for Industry (Draft Guidance). April 2022.

Lead (Pb)

Lead is a neurotoxic heavy metal with no safe exposure level. It contaminates food, consumer goods and drinking water, causing cognitive deficits, birth defects and cardiovascular disease. HMTC’s rigorous lead testing applies ALARA principles to protect infants and consumers and to prepare brands for tightening regulations.